European Federation of Pharmaceutical Industries and Associations
GPTKB entity
Statements (67)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:organization
|
| gptkbp:addresses |
healthcare challenges
|
| gptkbp:advocacy |
healthcare policies
|
| gptkbp:advocates_for |
patient rights
research funding intellectual property rights global health initiatives fair pricing regulatory harmonization patient access |
| gptkbp:collaborates_with |
gptkb:European_Union
government agencies patient organizations |
| gptkbp:collaboration |
between industry and academia
|
| gptkbp:conducts_research_on |
drug development
|
| gptkbp:contributes_to |
public health
|
| gptkbp:educational_programs |
medicinal products
|
| gptkbp:encourages |
ethical practices
|
| gptkbp:engages_in |
international collaborations
public education advocacy campaigns public affairs health economics health technology assessment |
| gptkbp:enhances |
health outcomes
healthcare delivery. |
| gptkbp:focus |
gptkb:pharmaceuticals
innovation |
| gptkbp:founded |
gptkb:1978
|
| gptkbp:has_partnerships_with |
health organizations
|
| gptkbp:has_role |
healthcare systems
drug pricing discussions |
| gptkbp:headquarters |
gptkb:Brussels,_Belgium
|
| gptkbp:hosts |
events
|
| https://www.w3.org/2000/01/rdf-schema#label |
European Federation of Pharmaceutical Industries and Associations
|
| gptkbp:influences |
gptkb:Health_Insurance
|
| gptkbp:initiatives |
health equity
vaccine development for patient safety |
| gptkbp:is_a_resource_for |
industry professionals
|
| gptkbp:issues |
position papers
|
| gptkbp:issues_reports_on |
industry trends
|
| gptkbp:membership |
national pharmaceutical industry associations
|
| gptkbp:number_of_members |
gptkb:33
|
| gptkbp:participates_in |
conferences
policy discussions |
| gptkbp:president |
gptkb:Pascal_Soriot
|
| gptkbp:promotes |
research and development
sustainable practices patient-centered care digital health solutions |
| gptkbp:provides |
guidance on regulations
|
| gptkbp:provides_guidance_on |
clinical trial regulations
|
| gptkbp:provides_information_on |
clinical trials
market access |
| gptkbp:provides_support_for |
rare diseases
|
| gptkbp:provides_training_for |
regulatory compliance
|
| gptkbp:raises_awareness_about |
antimicrobial resistance
|
| gptkbp:region |
gptkb:Europe
|
| gptkbp:supports |
clinical research
innovation ecosystems sustainable healthcare |
| gptkbp:website |
www.efpia.eu
|
| gptkbp:works_with |
stakeholders
|
| gptkbp:bfsParent |
gptkb:EFPIA
gptkb:Innovative_Medicines_Initiative |
| gptkbp:bfsLayer |
5
|